Test-retest reproducibility of 18F-MPPF PET in healthy humans: A reliability study

Journal of Nuclear Medicine

Volumn 48, Issue 8, 2007, Pages 1279-1288

  Costes, Nicolas ^a,b   Zimmer, Luc ^a,b,c   Reilhac, Anthonin ^a   Lavenne, Franck ^a   Ryvlin, Philippe ^b,c   Le Bars, Didier ^a  

^a CERMEP IMAGERIE DU VIVANT   (France)

^b UNIVERSITÉ LYON 1   (France)

^c IFNL   (France)

Author keywords

18F MPPF; PET; Reliability; Serotonin 5 HT1A receptors; Test retest study

Indexed keywords

2' METHOXYPHENYL (N 2' PYRIDINYL) 4 FLUOROBENZAMIDOETHYLPIPERAZINE F 18; FLUORINE 18; PIPERAZINE DERIVATIVE; SEROTONIN 1A RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANALYTICAL ERROR; ANATOMICAL VARIATION; ARTICLE; BRAIN REGION; CALCULATION; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; MALE; MATHEMATICAL MODEL; MEASUREMENT; NORMAL HUMAN; OUTCOME ASSESSMENT; PARAMETER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SIMULATION; TEST RETEST RELIABILITY;

ADULT; BRAIN; FEMALE; HUMANS; MALE; PIPERAZINES; POSITRON-EMISSION TOMOGRAPHY; PYRIDINES; RADIOPHARMACEUTICALS; RECEPTOR, SEROTONIN, 5-HT1A; REPRODUCIBILITY OF RESULTS;

EID: 34547752945     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.041905     Document Type: Article

References (30)

1. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083-1152.
2. Lanfumey L, Hamon M. 5-HT1 receptors. Curr Drug Targets CNS Neurol Disord. 2004;3:1-10.
3. 18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brain. Neuropharmacology. 2007;52:695-707.
4. 18F]MPPF PET study in narcolepsy. Neuroimage. 2006;30:341-348.
5. 18F]MPPF-PET study. Brain. 2004;127:900-913.
6. Merlet I, Ryvlin P, Costes N, et al. Statistical parametric mapping of 5-HT1A receptor binding in temporal lobe epilepsy with hippocampal ictal onset on intracranial EEG. Neuroimage. 2004;22:886-896.
7. 18F]MPPF positron emission tomography study. Biol Psychiatry. 2004;56:587-591.
8. 18F]MPPF in the nucleus raphe dorsalis of rat. J Neurosci. 2004;24:5420-5426.
9. Aznavour N, Rbah L, Riad M, Reilhac A, Costes N, Descarries LA. PET imaging study of 5-HT1A receptors in cat brain after acute and chronic fluoxetine treatment. Neuroimage. 2006;33:834-842.
10. 18F]p-MPPF. Nucl Med Biol. 2000;27:473-476.
11. 18F]MPPF PET kinetics for the determination of 5-HT1A concentration with multi-injection. J Cereb Blood Flow Metab. 2002;22:753-763.
12. 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging. J Nucl Med. 2005;46:1980-1989.
13. 18F]deuteoralteranserin. Psychiatry Res. 2001;106:81-93.
14. 11C]WAY-100635; considerations on the validity of cerebellum as a reference region. J Cereb Blood Flow Metab. 2007;27:185-195.
15. 11C]WAY-100635 PET studies. Nucl Med Biol. 2000;27:477-482.
16. Parsey RV, Slifstein M, Hwang DR, et al. Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tissue input functions. J Cereb Blood Flow Metab. 2000;20:1111-1133.
17. Goldberg DP, Hillier VF. A scaled version of the general health questionnaire. Psychol Med. 1979;9:139-145.
18. 18F]MPPF, a fluoro analog of WAY-100635. Nucl Med Biol. 1998;25:343-350.
19. Le Bars D, Bonmarchand G, Alvarez G, Lemaire C, Mosdzianowski C. New automation of MPPF using a coincidence synthesizer [abstract]. J Labelled Compd Radiopharm. 2001;44(suppl):S1045.
20. 18F]MPPF PET acquisitions incorporating inter-individual anatomical and biological variability. IEEE Trans Med Imaging. 2006;25:1431-1439.
21. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage. 1997;6:279-287.
22. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl Med Biol. 2000;27:661-670.
23. Hopkins WG. A new view of statistics. Internet Society for Sport Science. 2000; Available at: http://www.sportsci.org/resource/stats/. Accessed June 29, 2007.
24. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp. 1996;4:58-73.
25. Snedecor G, Cochran W, Cox D. Statistical Methods. Ames, IA: The Iowa State University Press; 1989.
26. 11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. J Nucl Med. 2006;47:208-214.
27. 11C-DASB in healthy humans: reproducibility and comparison of methods. J Nucl Med. 2006;47:815-826.
28. Rueter LE, Fornal CA, Jacobs BL. A critical review of 5-HT brain microdialysis and behavior. Rev Neurosci. 1997;8:117-137.
29. Meltzer CC, Drevets WC, Price JC, et al. Gender-specific aging effects on the serotonin 1A receptor. Brain Res. 2001;895:9-17.
30. Zimmer L, Riad M, Rbah L, et al. Toward brain imaging of serotonin 5-HT1A autoreceptor internalization. Neuroimage. 2004;22:1421-1426.